273 related articles for article (PubMed ID: 7666123)
1. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
Jauregui L; Minns P; Hageage G
J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
[TBL] [Abstract][Full Text] [Related]
2. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
Jauregui L; Minns P; Hageage G
Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
[TBL] [Abstract][Full Text] [Related]
3. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.
Weigelt JA
Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262
[TBL] [Abstract][Full Text] [Related]
4. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.
Löffler L; Bauernfeind A; Keyl W
Drugs; 1988; 35 Suppl 7():46-52. PubMed ID: 3265378
[TBL] [Abstract][Full Text] [Related]
5. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
[TBL] [Abstract][Full Text] [Related]
6. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
Dajani A
J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
[TBL] [Abstract][Full Text] [Related]
7. [Activity of an ampicillin/sulbactam combination in respiratory infections].
Mangiarotti P; Manara G; Grassi G; Gialdroni Grassi G
G Ital Chemioter; 1989; 36(1-3):39-44. PubMed ID: 2488911
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
Azimi PH; Barson WJ; Janner D; Swanson R
Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
[TBL] [Abstract][Full Text] [Related]
9. Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections.
Scalambrino S; Mangioni C; Milani R; Regallo M; Norchi S; Negri L; Carrera S; Vigano EF; Ruffilli MP; Canale MP
Suppl Int J Gynecol Obstet; 1989; 2():21-7. PubMed ID: 2679680
[TBL] [Abstract][Full Text] [Related]
10. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections.
Pareek A; Kulkarni M; Daga S; Deshpande A; Chandurkar N
Expert Opin Pharmacother; 2008 Nov; 9(16):2751-7. PubMed ID: 18937610
[TBL] [Abstract][Full Text] [Related]
12. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
Talan DA; Summanen PH; Finegold SM
Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
[TBL] [Abstract][Full Text] [Related]
13. Sultamicillin experiences in the field of internal medicine.
Hara K; Kobayashi H
APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
[TBL] [Abstract][Full Text] [Related]
14. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
Chan JC
Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
[TBL] [Abstract][Full Text] [Related]
15. A comparison of ampicillin/sulbactam and cefuroxime in the treatment of patients with bacterial infections of the lower respiratory tract.
Geckler RW
Clin Ther; 1994; 16(4):662-72. PubMed ID: 7982254
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.
Akova M; Ozcebe O; Güllü I; Unal S; Gür D; Akalin S; Tokgözoglu M; Telatar F; Akalin HE
J Chemother; 1996 Aug; 8(4):284-9. PubMed ID: 8873834
[TBL] [Abstract][Full Text] [Related]
17. [Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
Manncke K; Springsklee M; Heizmann WR; Sonntag HG
Med Klin (Munich); 1991 Sep; 86(9):454-60. PubMed ID: 1943983
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies on sulbactam/ampicillin in the field of pediatrics].
Iwata S; Yamada K; Sato Y; Ishikawa K; Akita H; Sunakawa K
Jpn J Antibiot; 1989 Mar; 42(3):598-611. PubMed ID: 2664249
[TBL] [Abstract][Full Text] [Related]
19. Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
Bisetti A; Grassi L; Scacciacillani E; Putti P
J Int Med Res; 1991; 19 Suppl 1():36A-43A. PubMed ID: 2060692
[TBL] [Abstract][Full Text] [Related]
20. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
Löffler L; Bauernfeind A; Keyl W; Hoffstedt B; Piergies A; Lenz W
Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
